An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer
Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) is resected at smaller sizes compared with its biologically distinct counterpart, pancreatic intraepithelial neoplasia (PanIN)-derived PDAC. Thus, experts proposed T1 sub-staging for IPMN-derived PDAC. How...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
November 2024
|
| In: |
Journal of the National Cancer Institute
Year: 2024, Volume: 116, Issue: 11, Pages: 1791-1797 |
| ISSN: | 1460-2105 |
| DOI: | 10.1093/jnci/djae166 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1093/jnci/djae166
|
| Author Notes: | Joseph R. Habib, Ingmar F. Rompen, Brady A. Campbell, Paul C.M. Andel, Benedict Kinny-Köster, Ryte Damaseviciute, D. Brock Hewitt, Greg D. Sacks, Ammar A .Javed, Marc G. Besselink, Hjalmar C. van Santvoort, Lois A. Daamen, Martin Loos, Jin He, I. Quintus Molenaar, Markus W. Büchler, Christopher L . Wolfgang |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1933361085 | ||
| 003 | DE-627 | ||
| 005 | 20250818092519.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250818s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jnci/djae166 |2 doi | |
| 035 | |a (DE-627)1933361085 | ||
| 035 | |a (DE-599)KXP1933361085 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Habib, Joseph |e VerfasserIn |0 (DE-588)1356321089 |0 (DE-627)1917306857 |4 aut | |
| 245 | 1 | 3 | |a An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer |c Joseph R. Habib, Ingmar F. Rompen, Brady A. Campbell, Paul C.M. Andel, Benedict Kinny-Köster, Ryte Damaseviciute, D. Brock Hewitt, Greg D. Sacks, Ammar A .Javed, Marc G. Besselink, Hjalmar C. van Santvoort, Lois A. Daamen, Martin Loos, Jin He, I. Quintus Molenaar, Markus W. Büchler, Christopher L . Wolfgang |
| 264 | 1 | |c November 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 19. Juli 2024 | ||
| 500 | |a Gesehen am 18.08.2025 | ||
| 520 | |a Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) is resected at smaller sizes compared with its biologically distinct counterpart, pancreatic intraepithelial neoplasia (PanIN)-derived PDAC. Thus, experts proposed T1 sub-staging for IPMN-derived PDAC. However, this has never been validated.Consecutive upfront surgery patients with IPMN-derived PDAC from 5 international high-volume centers were classified by the proposed T1 sub-staging classification (T1a ≤0.5, T1b >0.5 and ≤1.0, and T1c >1.0 and ≤2.0 cm) using the invasive component size. Kaplan-Meier and log-rank tests were used to compare overall survival (OS). A multivariable Cox regression was used to determine hazard ratios (HRs) with confidence intervals (95% CIs).Among 747 patients, 69 (9.2%), 50 (6.7%), 99 (13.0%), and 531 patients (71.1%), comprised the T1a, T1b, T1c, and T2-4 subgroups, respectively. Increasing T-stage was associated with elevated CA19-9, poorer grade, nodal positivity, R1 margin, and tubular subtype. Median OS for T1a, T1b, T1c, and T2-4 were 159.0 (95% CI = 126.0 to NR), 128.8 (98.3 to NR), 77.6 (48.3 to 108.2), and 31.4 (27.5 to 37.7) months, respectively (P < .001). OS decreased with increasing T-stage for all pairwise comparisons (all P < .05). After risk adjustment, older than age 65, elevated CA19-9, T1b [HR = 2.55 (1.22 to 5.32)], T1c [HR = 3.04 (1.60 to 5.76)], and T2-4 [HR = 3.41 (1.89 to 6.17)] compared with T1a, nodal positivity, R1 margin, and no adjuvant chemotherapy were associated with worse OS. Disease recurrence was more common in T2-4 tumors (56.4%) compared with T1a (18.2%), T1b (23.9%), and T1c (36.1%, P < .001).T1 sub-staging of IPMN-derived PDAC is valid and has significant prognostic value. Advancing T1 sub-stage is associated with worse histopathology, survival, and recurrence. T1 sub-staging is recommended for future guidelines. | ||
| 700 | 1 | |a Rompen, Ingmar F. |d 1994- |e VerfasserIn |0 (DE-588)1260414086 |0 (DE-627)1807281671 |4 aut | |
| 700 | 1 | |a Campbell, Brady A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Andel, Paul C. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kinny-Köster, Benedict |d 1991- |e VerfasserIn |0 (DE-588)1144960118 |0 (DE-627)1005123780 |0 (DE-576)495535362 |4 aut | |
| 700 | 1 | |a Damaseviciute, Ryte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brock Hewitt, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sacks, Greg D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Javed, Ammar A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Besselink, Marc G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Santvoort, Hjalmar C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Daamen, Lois A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loos, Martin |d 1974- |e VerfasserIn |0 (DE-588)13060044X |0 (DE-627)504175025 |0 (DE-576)298290626 |4 aut | |
| 700 | 1 | |a He, Jin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Quintus Molenaar, I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 700 | 1 | |a Wolfgang, Christopher L. |e VerfasserIn |0 (DE-588)1077118961 |0 (DE-627)836041518 |0 (DE-576)446002682 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a National Cancer Institute |t Journal of the National Cancer Institute |d Oxford : Oxford Univ. Press, 1941 |g 116(2024), 11 vom: Nov., Seite 1791-1797 |w (DE-627)265780713 |w (DE-600)1465951-7 |w (DE-576)074959581 |x 1460-2105 |7 nnas |
| 773 | 1 | 8 | |g volume:116 |g year:2024 |g number:11 |g month:11 |g pages:1791-1797 |g extent:7 |a An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1093/jnci/djae166 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250818 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 16 | ||
| 998 | |g 13060044X |a Loos, Martin |m 13060044X:Loos, Martin |d 910000 |d 910200 |e 910000PL13060044X |e 910200PL13060044X |k 0/910000/ |k 1/910000/910200/ |p 13 | ||
| 998 | |g 1144960118 |a Kinny-Köster, Benedict |m 1144960118:Kinny-Köster, Benedict |d 910000 |d 910200 |e 910000PK1144960118 |e 910200PK1144960118 |k 0/910000/ |k 1/910000/910200/ |p 5 | ||
| 998 | |g 1260414086 |a Rompen, Ingmar F. |m 1260414086:Rompen, Ingmar F. |d 910000 |d 910200 |e 910000PR1260414086 |e 910200PR1260414086 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 999 | |a KXP-PPN1933361085 |e 4758565104 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"National Cancer InstituteJournal of the National Cancer Institute","recId":"265780713","part":{"text":"116(2024), 11 vom: Nov., Seite 1791-1797","extent":"7","volume":"116","pages":"1791-1797","issue":"11","year":"2024"},"id":{"issn":["1460-2105"],"zdb":["1465951-7"],"eki":["265780713"]},"origin":[{"publisherPlace":"Oxford","publisher":"Oxford Univ. Press","dateIssuedKey":"1941","dateIssuedDisp":"1941-"}],"pubHistory":["1.1940/41(1941) -"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"National Cancer Institute","role":"aut"}],"note":["Gesehen am 18.02.14"],"titleAlt":[{"title":"Journal of the National Cancer Institute online"},{"title":"JNCI"}],"title":[{"subtitle":"JNCI","title":"Journal of the National Cancer Institute","title_sort":"Journal of the National Cancer Institute"}]}],"note":["Online veröffentlicht: 19. Juli 2024","Gesehen am 18.08.2025"],"id":{"eki":["1933361085"],"doi":["10.1093/jnci/djae166"]},"origin":[{"dateIssuedDisp":"November 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Joseph R. Habib, Ingmar F. Rompen, Brady A. Campbell, Paul C.M. Andel, Benedict Kinny-Köster, Ryte Damaseviciute, D. Brock Hewitt, Greg D. Sacks, Ammar A .Javed, Marc G. Besselink, Hjalmar C. van Santvoort, Lois A. Daamen, Martin Loos, Jin He, I. Quintus Molenaar, Markus W. Büchler, Christopher L . Wolfgang"]},"recId":"1933361085","person":[{"display":"Habib, Joseph","role":"aut","given":"Joseph","family":"Habib"},{"family":"Rompen","role":"aut","given":"Ingmar F.","display":"Rompen, Ingmar F."},{"family":"Campbell","role":"aut","given":"Brady A.","display":"Campbell, Brady A."},{"family":"Andel","given":"Paul C. M.","role":"aut","display":"Andel, Paul C. M."},{"display":"Kinny-Köster, Benedict","family":"Kinny-Köster","role":"aut","given":"Benedict"},{"family":"Damaseviciute","role":"aut","given":"Ryte","display":"Damaseviciute, Ryte"},{"family":"Brock Hewitt","given":"D.","role":"aut","display":"Brock Hewitt, D."},{"given":"Greg D.","role":"aut","family":"Sacks","display":"Sacks, Greg D."},{"family":"Javed","role":"aut","given":"Ammar A.","display":"Javed, Ammar A."},{"display":"Besselink, Marc G.","family":"Besselink","role":"aut","given":"Marc G."},{"role":"aut","given":"Hjalmar C.","family":"van Santvoort","display":"van Santvoort, Hjalmar C."},{"display":"Daamen, Lois A.","role":"aut","given":"Lois A.","family":"Daamen"},{"role":"aut","given":"Martin","family":"Loos","display":"Loos, Martin"},{"display":"He, Jin","family":"He","given":"Jin","role":"aut"},{"display":"Quintus Molenaar, I.","family":"Quintus Molenaar","role":"aut","given":"I."},{"role":"aut","given":"Markus W.","family":"Büchler","display":"Büchler, Markus W."},{"display":"Wolfgang, Christopher L.","role":"aut","given":"Christopher L.","family":"Wolfgang"}],"title":[{"title_sort":"international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer","title":"An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer"}],"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a HABIBJOSEPINTERNATIO2024 | ||